Accrued Liabilities - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

NuVasive Inc
Accrued Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Accrued Liabilities
$60.7m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.2B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
6%
Stryker Corp
NYSE:SYK
Accrued Liabilities
$2.9B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
1%
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$773.3m
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
14%

See Also

What is NuVasive Inc's Accrued Liabilities?
Accrued Liabilities
60.7m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Accrued Liabilities amounts to 60.7m USD.

What is NuVasive Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
11%

Over the last year, the Accrued Liabilities growth was -14%. The average annual Accrued Liabilities growth rates for NuVasive Inc have been 7% over the past three years , 3% over the past five years , and 11% over the past ten years .

Back to Top